SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peng Peng Ip, Hans W. Nijman, Jan Wilschut, Toos Daemen, Therapeutic vaccination against chronic hepatitis C virus infection, Antiviral Research, 2012, 96, 1, 36

    CrossRef

  2. 2
    Viet Loan Dao Thi, Marlène Dreux, François-Loïc Cosset, Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation, Expert Reviews in Molecular Medicine, 2011, 13,

    CrossRef

  3. 3
    Eva Herker, Melanie Ott, Unique ties between hepatitis C virus replication and intracellular lipids, Trends in Endocrinology & Metabolism, 2011, 22, 6, 241

    CrossRef

  4. 4
    Olga V. Masalova, Ekaterina I. Lesnova, Alexei V. Pichugin, Tatiana M. Melnikova, Vadim V. Grabovetsky, Natalia V. Petrakova, Olga A. Smirnova, Alexander V. Ivanov, Alexei D. Zaberezhny, Ravshan I. Ataullakhanov, Maria G. Isaguliants, Alla A. Kushch, The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization, Vaccine, 2010, 28, 8, 1987

    CrossRef

  5. 5
    Françoise Stoll-Keller, Heidi Barth, Samira Fafi-Kremer, Mirjam B Zeisel, Thomas F Baumert, Development of hepatitis C virus vaccines: challenges and progress, Expert Review of Vaccines, 2009, 8, 3, 333

    CrossRef

  6. 6
    Mirjam B Zeisel, Thomas F Baumert, HCV entry and neutralizing antibodies: lessons from viral variants, Future Microbiology, 2009, 4, 5, 511

    CrossRef

  7. 7
    L. Alvarez-Lajonchere, N. H. Shoukry, B. Grá, Y. Amador-Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González-Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas-Carrera, Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial, Journal of Viral Hepatitis, 2009, 16, 3
  8. 8
    S. Fafi-Kremer, M.B. Zeisel, E. Schvoerer, E. Soulier, F. Habersetzer, P. Wolf, M. Doffoel, T.F. Baumert, F. Stoll-Keller, Anticorps neutralisants dirigés contre le virus de l’hépatite C, Gastroentérologie Clinique et Biologique, 2008, 32, 5, 491

    CrossRef

  9. 9
    Mirjam B. Zeisel, François-Loïc Cosset, Thomas F. Baumert, Host neutralizing responses and pathogenesis of hepatitis C virus infection, Hepatology, 2008, 48, 1
  10. 10
    B A Guinn, R Mulherkar, International progress in cancer gene therapy, Cancer Gene Therapy, 2008, 15, 12, 765

    CrossRef